Delivery Order SPE2DB20D2104-SPE2DB24FR62X
- Not listed
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract has a firm fixed price of $7,905.73 and an ultimate completion date of July 2, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract is not set aside for any specific business type....
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $18,726.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 28, 2024 and is a Firm Fixed Price Delivery Order. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corporation, a major pharmaceutical distribution company, with a ceiling value of $3,421.00. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025....
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price of $1,578.17 and an ultimate completion date of July 17, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract, valued at $19,855.67, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,808.93 and an ultimate completion date of February 15, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $16,170.49 and was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 18, 2024, with a completion date of January 19, 2024. The contract is a delivery order and is priced as a firm fixed price. It is not designated as a set-aside contract. Amerisourcebergen...
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 11, 2025, with a ceiling value of $19,855.67 and a completion date of March 12, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug...
- This federal contract award from the Defense Logistics Agency (DLA) is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the agency. The $7,593.85 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is a key vendor for federal healthcare programs. The contract has an ultimate completion date of July 10, 2024 and is a Delivery Order under a larger Indefinite Delivery...
- This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $16,902.55 and is a Firm Fixed Price Delivery Order with a completion date of June 24, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and is an open competition award....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR62XDelivery Order
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, as a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award has a ceiling value of $4,027.70 and a completion date of December 15, 2023. There is no set-aside designation for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 12/14/23 |